Takeda Pharmaceutical Company Limited Postemployment Benefit Expense Defined Benefit Plans
Takeda Pharmaceutical Company Limited (TAK) reported Postemployment Benefit Expense Defined Benefit Plans of JPY 7.96 billion for the 12-month period ending 2021-03-31, per its 20-F filed 2021-06-29.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2021-06-29
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|
| 2021-03-31 | 7.96B JPY 20-F · filed 2021-06-29 |
| 2020-03-31 | 16.26B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 11.41B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 10.35B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 11.99B JPY 20-F · filed 2019-06-27 |